A year or so after Dr. Robert Popovieh arrived in Seattle in 1965 to
begin working on his doctoral thesis under Dr. A.L. Babb, we had just
begun work to try to prove the prediction that the peritoneum had a
higher permeability to 'middle molecules' than hemodialysis membranes
[I]. Several years later, when Dr. Popovieh accepted a position at the
University of Texas in Austin, he decided to concentrate his research
efforts in the area of peritoneal dialysis and everyone knows how
successful that effort has become [2]. Indeed, because of continuous
ambulatory peritoneal dialysis (CAPD), long-term per- itoneal dialysis
after a two-decade incubation period is finally becoming an equal option
to hemodialysis and transplantation in the management of chronic renal
failure. For me this development represents final vindication of a
twenty-year effort to help promote peritoneal dialysis, often in the
face of enormaus opposition. I particularly remember a policy meeting at
the NIH a few years back in which it was decided by my colleagues on the
committee that long term peritoneal dialysis had no future and therefore
no funds for projects in this area would be forthcoming. Based on the
excellent results that Boen and later Tenckhoff had been getting in our
Seattle program, I knew the committee was wrong and tried to convince
them otherwise. Naturally, being the only favorable vote, I failed. I
often wonder how many years this decision and others like it set back
peritoneal dialysis.